Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 May;36(1):35–45. doi: 10.1111/j.1476-5381.1969.tb08301.x

The cardio-toxicity of isoprenaline during hypoxia

J M Collins, D G McDevitt, R G Shanks, J G Swanton
PMCID: PMC1703542  PMID: 5768127

Abstract

1. The effects of the intravenous injection of isoprenaline on heart rate and arterial pressure has been studied in dogs artificially respired with room air or with 12% oxygen—88% nitrogen.

2. In dogs breathing room air, isoprenaline in doses from 0·02 to 500 μg/kg increased heart rate and reduced arterial pressure. Ventricular fibrillation was produced in one out of three dogs given 250 μg/kg. This was the only dog breathing room air which was killed by isoprenaline.

3. In dogs breathing room air the repeated intravenous injection at 5-min intervals of 2·5 μg/kg increased heart rate and reduced arterial pressure. No ill effects were produced by six doses.

4. In dogs respired with 12% oxygen—88% nitrogen the PaO2 was reduced from 84 to 38 mm Hg with no changes in PaCO2. In these dogs death was produced by doses of isoprenaline which in dogs breathing room air produced normal responses.

5. The fatal dose of isoprenaline (10-50 μg/kg) reduced heart rate and arterial and pulse pressures; sinus rhythm persisted until arterial pressure was less than 50 mm Hg. Ventricular fibrillation did not occur; death occurred from cardiac asystole.

6. Death was produced in a similar way in dogs with hypoxaemia by giving four or five doses of isoprenaline (2·5 μg/kg) at 5-min intervals or by two doses of 25 μg/kg.

7. The final reduction in arterial pressure during a fatal response resulted from a reduction in cardiac contractility.

8. These lethal effects of isoprenaline could be prevented by pretreatment with propranolol.

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN O. S., ENGEL K., JORGENSEN K., ASTRUP P. A Micro method for determination of pH, carbon dioxide tension, base excess and standard bicarbonate in capillary blood. Scand J Clin Lab Invest. 1960;12:172–176. doi: 10.3109/00365516009062419. [DOI] [PubMed] [Google Scholar]
  2. BUTTERWORTH K. R. THE BETA-ADRENERGIC BLOCKING AND PRESSOR ACTION OF ISOPRENALINE IN THE CAT. Br J Pharmacol Chemother. 1963 Oct;21:378–392. doi: 10.1111/j.1476-5381.1963.tb01536.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Harris W. S., Schoenfeld C. D., Brooks R. H., Weissler A. M. Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in man. Am J Cardiol. 1966 Apr;17(4):484–492. doi: 10.1016/0002-9149(66)90238-4. [DOI] [PubMed] [Google Scholar]
  4. KRASNOW N., ROLETT E. L., YURCHAK P. M., HOOD W. B., Jr, GORLIN R. ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE. Am J Med. 1964 Oct;37:514–525. doi: 10.1016/0002-9343(64)90065-8. [DOI] [PubMed] [Google Scholar]
  5. Noble M. I., Gabe I. T., Trenchard D., Guz A. Blood pressure and flow in the ascending aorta of conscious dogs. Cardiovasc Res. 1967 Jan;1(1):9–20. doi: 10.1093/cvr/1.1.9. [DOI] [PubMed] [Google Scholar]
  6. Palmer K. N., Diament M. L. Spirometry and blood-gas tensions in bronchial asthma and chronic bronchitis. Lancet. 1967 Aug 19;2(7512):383–384. doi: 10.1016/s0140-6736(67)92005-3. [DOI] [PubMed] [Google Scholar]
  7. Paterson J. W., Conolly M. E., Davies D. S., Dollery C. T. Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet. 1968 Aug 24;2(7565):426–429. doi: 10.1016/s0140-6736(68)90467-4. [DOI] [PubMed] [Google Scholar]
  8. Read J. The reported increase in mortality from asthma: a clinico-functional analysis. Med J Aust. 1968 May 25;1(21):879–884. doi: 10.5694/j.1326-5377.1968.tb28997.x. [DOI] [PubMed] [Google Scholar]
  9. Shanks R. G. The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog. Br J Pharmacol Chemother. 1966 Feb;26(2):322–333. doi: 10.1111/j.1476-5381.1966.tb01911.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Speizer F. E., Doll R., Heaf P., Strang L. B. Investigation into use of drugs preceding death from asthma. Br Med J. 1968 Feb 10;1(5588):339–343. doi: 10.1136/bmj.1.5588.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tai E., Read J. Blood-gas tensions in bronchial asthma. Lancet. 1967 Mar 25;1(7491):644–646. doi: 10.1016/s0140-6736(67)92541-x. [DOI] [PubMed] [Google Scholar]
  13. Valabhji P. Gas exchange in the acute and asymptomatic phases of asthma breathing air and oxygen. Clin Sci. 1968 Jun;34(3):431–440. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES